MICHAEL BIGHAM Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL BIGHAM.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL BIGHAM. MICHAEL BIGHAM is Director in XENOGEN CORP ($XGEN) and Chairman and CEO in Paratek Pharmaceuticals, Inc. ($PRTK) and Director in Paratek Pharmaceuticals, Inc. ($PRTK) and Exec. Chairman of the Board in Paratek Pharmaceuticals, Inc. ($PRTK) and Director in Adamas Pharmaceuticals Inc ($ADMS).
Latest Insider Trading Transactions of MICHAEL BIGHAM
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADMS, PRTK, XGEN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 04 2021 | ADMS | Adamas Pharmaceuti ... | BIGHAM MICHAEL | Director | Option Exercise | A | 5.21 | 10,000 | 52,100 | 10,000 | |
| Jun 04 2021 | ADMS | Adamas Pharmaceuti ... | BIGHAM MICHAEL | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
| Apr 01 2021 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Exec. Chairman of t ... | Grant | A | 0.00 | 281,250 | 0 | 827,767 | 546.5 K to 827.8 K (+51.46 %) |
| Dec 15 2020 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Exec. Chairman of t ... | Sell | S | 6.71 | 26,063 | 174,883 | 546,517 | 572.6 K to 546.5 K (-4.55 %) |
| Dec 15 2020 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Exec. Chairman of t ... | Sell | S | 6.95 | 18,337 | 127,442 | 572,580 | 590.9 K to 572.6 K (-3.10 %) |
| Nov 16 2020 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Exec. Chairman of t ... | Sell | S | 5.93 | 26,250 | 155,663 | 590,917 | 617.2 K to 590.9 K (-4.25 %) |
| Nov 16 2020 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Exec. Chairman of t ... | Grant | A | 0.00 | 75,000 | 0 | 617,167 | 542.2 K to 617.2 K (+13.83 %) |
| Jun 05 2020 | ADMS | Adamas Pharmaceuti ... | BIGHAM MICHAEL | Director | Option Exercise | A | 2.70 | 10,000 | 27,000 | 10,000 | |
| Jun 05 2020 | ADMS | Adamas Pharmaceuti ... | BIGHAM MICHAEL | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| May 14 2020 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Exec. Chairman of t ... | Sell | S | 4.68 | 12,250 | 57,330 | 542,167 | 554.4 K to 542.2 K (-2.21 %) |
| Feb 21 2020 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Director | Grant | A | 0.00 | 135,000 | 0 | 554,417 | 419.4 K to 554.4 K (+32.19 %) |
| Oct 08 2019 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Director | Grant | A | 0.00 | 28,000 | 0 | 419,417 | 391.4 K to 419.4 K (+7.15 %) |
| Jun 06 2019 | ADMS | Adamas Pharmaceuti ... | BIGHAM MICHAEL | Director | Option Exercise | A | 4.80 | 10,000 | 48,000 | 10,000 | |
| Feb 28 2019 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Grant | A | 0.00 | 120,000 | 0 | 391,417 | 271.4 K to 391.4 K (+44.21 %) |
| Feb 04 2019 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Grant | A | 0.00 | 35,000 | 0 | 271,417 | 236.4 K to 271.4 K (+14.80 %) |
| Feb 04 2019 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Gift | G | 0.00 | 20,050 | 0 | 236,417 | 256.5 K to 236.4 K (-7.82 %) |
| Dec 14 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 6.76 | 8,400 | 56,784 | 256,467 | 264.9 K to 256.5 K (-3.17 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 8.96 | 6,300 | 56,448 | 264,867 | 271.2 K to 264.9 K (-2.32 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 8.96 | 6,300 | 56,448 | 264,867 | 271.2 K to 264.9 K (-2.32 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Grant | A | 0.00 | 14,000 | 0 | 271,167 | 257.2 K to 271.2 K (+5.44 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Grant | A | 0.00 | 14,000 | 0 | 271,167 | 257.2 K to 271.2 K (+5.44 %) |
| Oct 04 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 9.82 | 16,313 | 160,194 | 257,167 | 273.5 K to 257.2 K (-5.96 %) |
| Oct 04 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Grant | A | 0.00 | 60,000 | 0 | 273,480 | 213.5 K to 273.5 K (+28.11 %) |
| Oct 04 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Grant | A | 0.00 | 36,250 | 0 | 213,480 | 177.2 K to 213.5 K (+20.45 %) |
| Jul 05 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 9.97 | 22,500 | 224,325 | 177,230 | 199.7 K to 177.2 K (-11.27 %) |
| Jun 07 2018 | ADMS | Adamas Pharmaceuti ... | BIGHAM MICHAEL | Director | Option Exercise | A | 27.98 | 10,000 | 279,800 | 10,000 | |
| Apr 10 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 12.70 | 8,700 | 110,490 | 199,730 | 208.4 K to 199.7 K (-4.17 %) |
| Apr 10 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 12.70 | 8,700 | 110,490 | 199,730 | 208.4 K to 199.7 K (-4.17 %) |
| Apr 05 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Grant | A | 0.00 | 21,750 | 0 | 208,430 | 186.7 K to 208.4 K (+11.65 %) |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Grant | A | 0.00 | 63,000 | 0 | 186,680 | 123.7 K to 186.7 K (+50.94 %) |
| Feb 07 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 14.22 | 4,000 | 56,880 | 123,680 | 127.7 K to 123.7 K (-3.13 %) |
| Jul 21 2017 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Option Exercise | M | 4.30 | 23,255 | 99,997 | 121,838 | |
| Jul 21 2017 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Buy | M | 4.30 | 23,255 | 99,997 | 127,680 | 104.4 K to 127.7 K (+22.27 %) |
| Jul 06 2017 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 23.58 | 5,075 | 119,662 | 104,425 | 109.5 K to 104.4 K (-4.63 %) |
| Jul 06 2017 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Grant | A | 0.00 | 14,500 | 0 | 109,500 | 95 K to 109.5 K (+15.26 %) |
| Jun 02 2017 | ADMS | Adamas Pharmaceuti ... | BIGHAM MICHAEL | Director | Option Exercise | A | 16.27 | 15,000 | 244,050 | 15,000 | |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 15.05 | 1,752 | 26,368 | 95,000 | 96.8 K to 95 K (-1.81 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 15.08 | 32 | 482 | 96,752 | 96.8 K to 96.8 K (-0.03 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 15.10 | 2,104 | 31,770 | 96,784 | 98.9 K to 96.8 K (-2.13 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 15.15 | 1,082 | 16,392 | 98,888 | 100 K to 98.9 K (-1.08 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 15.20 | 30 | 456 | 99,970 | 100 K to 100 K (-0.03 %) |
| Feb 06 2017 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Option Exercise | A | 15.10 | 72,500 | 1,094,750 | 72,500 | |
| Sep 22 2016 | ADMS | Adamas Pharmaceuti ... | BIGHAM MICHAEL | Director | Option Exercise | A | 18.09 | 30,000 | 542,700 | 30,000 | |
| Jun 27 2016 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Buy | P | 13.45 | 20,000 | 269,014 | 100,000 | 80 K to 100 K (+25.00 %) |
| Feb 08 2016 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Option Exercise | A | 14.05 | 60,000 | 843,000 | 60,000 | |
| Feb 08 2016 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Grant | A | 0.00 | 30,000 | 0 | 80,000 | 50 K to 80 K (+60.00 %) |
| Jul 02 2015 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Option Exercise | A | 25.77 | 100,000 | 2,577,000 | 100,000 | |
| Jul 02 2015 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
| Aug 15 2005 | XGEN | XENOGEN CORP | BIGHAM MICHAEL | Director | Option Exercise | P | 3.29 | 154,639 | 508,762 | 154,639 | |
| Aug 15 2005 | XGEN | XENOGEN CORP | BIGHAM MICHAEL | Director | Option Exercise | P | 3.29 | 2,062 | 6,784 | 2,062 | |
| Aug 15 2005 | XGEN | XENOGEN CORP | BIGHAM MICHAEL | Director | Option Exercise | P | 3.29 | 47,309 | 155,647 | 47,309 | |
| Aug 15 2005 | XGEN | XENOGEN CORP | BIGHAM MICHAEL | Director | Option Exercise | P | 3.29 | 78,979 | 259,841 | 78,979 | |
| Aug 15 2005 | XGEN | XENOGEN CORP | BIGHAM MICHAEL | Director | Option Exercise | P | 3.29 | 129,381 | 425,663 | 129,381 | |
| Aug 15 2005 | XGEN | XENOGEN CORP | BIGHAM MICHAEL | Director | Buy | P | 2.91 | 515,464 | 1,500,000 | 515,464 | 0 to 515.5 K |
| Aug 15 2005 | XGEN | XENOGEN CORP | BIGHAM MICHAEL | Director | Buy | P | 2.91 | 6,873 | 20,000 | 20,719 | 13.8 K to 20.7 K (+49.64 %) |
| Aug 15 2005 | XGEN | XENOGEN CORP | BIGHAM MICHAEL | Director | Buy | P | 2.91 | 157,698 | 458,901 | 475,398 | 317.7 K to 475.4 K (+49.64 %) |
| Aug 15 2005 | XGEN | XENOGEN CORP | BIGHAM MICHAEL | Director | Buy | P | 2.91 | 263,265 | 766,101 | 793,641 | 530.4 K to 793.6 K (+49.64 %) |
| Aug 15 2005 | XGEN | XENOGEN CORP | BIGHAM MICHAEL | Director | Buy | P | 2.91 | 431,271 | 1,254,999 | 1,300,117 | 868.8 K to 1.3 M (+49.64 %) |
| Jul 23 2004 | XGEN | XENOGEN CORP | BIGHAM MICHAEL | Director | Option Exercise | C | 0.00 | 13,846 | 0 | 0 | |
| Jul 23 2004 | XGEN | XENOGEN CORP | BIGHAM MICHAEL | Director | Option Exercise | C | 0.00 | 317,700 | 0 | 0 | |
| Jul 23 2004 | XGEN | XENOGEN CORP | BIGHAM MICHAEL | Director | Option Exercise | C | 0.00 | 530,376 | 0 | 0 | |
| Jul 23 2004 | XGEN | XENOGEN CORP | BIGHAM MICHAEL | Director | Option Exercise | C | 0.00 | 868,846 | 0 | 0 | |
| Jul 23 2004 | XGEN | XENOGEN CORP | BIGHAM MICHAEL | Director | Buy | C | 0.00 | 13,846 | 0 | 13,846 | 0 to 13.8 K |
| Jul 23 2004 | XGEN | XENOGEN CORP | BIGHAM MICHAEL | Director | Buy | C | 0.00 | 317,700 | 0 | 317,700 | 0 to 317.7 K |
| Jul 23 2004 | XGEN | XENOGEN CORP | BIGHAM MICHAEL | Director | Buy | C | 0.00 | 530,376 | 0 | 530,376 | 0 to 530.4 K |
| Jul 23 2004 | XGEN | XENOGEN CORP | BIGHAM MICHAEL | Director | Buy | C | 0.00 | 868,846 | 0 | 868,846 | 0 to 868.8 K |
| Jul 21 2004 | XGEN | XENOGEN CORP | BIGHAM MICHAEL | Director | Grant | A | 0.00 | 5,715 | 0 | 5,715 | 0 to 5.7 K |
| Jul 21 2004 | XGEN | XENOGEN CORP | BIGHAM MICHAEL | Director | Grant | A | 0.00 | 5,715 | 0 | 5,715 | 0 to 5.7 K |
Page: 1